Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Prospective Hemolytic Disease of the Fetus and Newborn Registry

NCT07194070 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT07194070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07194070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Prospective Hemolytic Disease of the Fetus and Newborn Registry
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Recruiting
Start date
December 17, 2025
Completion date
September 30, 2030
Enrollment
175 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hemolytic disease of the fetus and newborn